Episurf Medical AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 4.5 million compared to SEK 4.9 million a year ago. Revenue was SEK 4.6 million compared to SEK 5.1 million a year ago. Net loss was SEK 21.9 million compared to SEK 23.7 million a year ago. Basic loss per share from continuing operations was SEK 0.08 compared to SEK 0.09 a year ago. Diluted loss per share from continuing operations was SEK 0.08 compared to SEK 0.09 a year ago.
For the full year, sales was SEK 19.8 million compared to SEK 17.9 million a year ago. Revenue was SEK 20.1 million compared to SEK 18.2 million a year ago. Net loss was SEK 94.8 million compared to SEK 77.3 million a year ago. Basic loss per share from continuing operations was SEK 0.36 compared to SEK 0.29 a year ago. Diluted loss per share from continuing operations was SEK 0.36 compared to SEK 0.29 a year ago.